Modeling an evaluation of the efficacy of the novel neuroanalgesic drug mirogabalin for diabetic peripheral neuropathic pain and postherpetic neuralgia therapy
Open Access
- 21 April 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 197, 106777
Abstract
No abstract availableKeywords
Funding Information
- Fujian Provincial Natural Science Foundation
This publication has 27 references indexed in Scilit:
- Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, StudyPain and Therapy, 2020
- Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain CliniciansJournal of Anesthesia, 2018
- Topical Treatment of Peripheral Neuropathic Pain: Applying the EvidenceJournal of Pain and Symptom Management, 2017
- The Many Flavors of Model‐Based Meta‐Analysis: Part I—Introduction and Landmark DataCPT: Pharmacometrics & Systems Pharmacology, 2015
- Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During Drug DevelopmentClinical Pharmacology & Therapeutics, 2012
- Model-Based Meta-Analysis for Comparative Efficacy and Safety: Application in Drug Development and BeyondClinical Pharmacology & Therapeutics, 2011
- Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE MethodPharmaceutical Research, 2007
- Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinProceedings of the National Academy of Sciences, 2006
- Calcium channel α2δ1 subunit mediates spinal hyperexcitability in pain modulationPain, 2006
- Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: a bootstrap modification of standard two-stage (STS) method for phase I trialStatistics in Medicine, 1999